Page last updated: 2024-08-17

levodopa and Ambulation Disorders, Neurologic

levodopa has been researched along with Ambulation Disorders, Neurologic in 171 studies

Research

Studies (171)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.58)	18.2507
2000's	53 (30.99)	29.6817
2010's	79 (46.20)	24.3611
2020's	38 (22.22)	2.80

Authors

Authors	Studies
Boca, M; Kobylecki, C; Michou, E; Shiderova, I	1
Ávila de Oliveira, J; Bazán, PR; Bernardo, C; Carvalho, MJ; Coelho, DB; de Lima-Pardini, AC; de Oliveira, CEN; de Oliveira, LDS; Hondo, SM; Los Angeles, E; Treza, RC	1
Chung, SJ; Hwang, YS; Jeon, SR; Jo, S; Kim, MS; Lee, J; Lee, SH; Park, KW	1
Cossu, G; Di Fonzo, A; Falla, M	1
Branković, M; Dragašević-Mišković, NT; Jančić, I; Kostić, VS; Marjanović, A; Milićević, O; Milovanović, A; Petrović, I; Radojević, B; Savić, MM; Stanisavljević, D; Svetel, M	1
Doerhoff, S; Glover, A; Landes, RD; Pillai, L; Virmani, T	1
Chung, SJ; Jeong, SH; Lee, HS; Lee, PH; Sohn, YH	1
Bergmann, L; Fasano, A; Femia, S; Gurevich, T; Kovács, N; Parra, JC; Sanchez-Soliño, O; Svenningsson, P; Szász, J; Vela-Desojo, L	1
Amato, F; Artusi, CA; Calandra-Buonaura, G; Contin, M; Cortelli, P; Giannini, G; Imbalzano, G; Ledda, C; Lopiano, L; Olmo, G; Rinaldi, D; Romagnolo, A; Sambati, L; Zibetti, M	1
Atri, A; Moreno, AM; Paquette, C; Potvin-Desrochers, A	1
Cao, X; Gan, C; Ji, M; Sun, H; Wang, L; Yuan, Y; Zhang, H; Zhang, K	1
Gordon, E; Graham, L; Hughes, E; Monaghan, AS; Morris, R; Peterson, DS	1
Factor, SA; Goldstein, FC; McKay, JL; Nye, J; Smith, Y; Sommerfeld, B; Weinshenker, D	1
Chen, Q; Hallett, M; Hattori, T; Hirakawa, A; Hirata, K; Kina, S; Matsubayashi, T; Ohara, M; Shimano, K; Yokota, T	1
Bernhard, D; Clifford, GD; Esper, CD; Factor, SA; Genias, I; Kwon, H; McKay, JL	1
Factor, SA; Glover, A; Landes, RD; Larson-Prior, L; Pillai, L; Prior, F; Virmani, T	1
Cao, X; Gan, C; Gao, M; Ji, M; Shan, A; Sun, H; Wang, L; Yuan, Y; Zhang, H; Zhang, K	1
Adamson, MB; Gilmore, G; Gouelle, A; Jog, M; Pieterman, M	1
Bereau, M; Bloem, BR; Nonnekes, J	1
Ceballos-Baumann, AO; Fietzek, UM; Schulz, SJ; Ziegler, K	1
Fung, VSC; Griffith, J; Mahant, N; Martin, AJ; Morales-Briceño, H; Tsui, D	1
Chung, SJ; Lee, HS; Lee, PH; Lee, YH; Sohn, YH; Yoo, HS	1
Bloem, BR; Nonnekes, J	1
Claus, I; Dziewas, R; Labeit, B; Muhle, P; Suntrup-Krueger, S; Suttrup, J; Warnecke, T	1
Bernad-Elazari, H; Dagan, M; Gazit, E; Giladi, N; Hausdorff, JM; Herman, T; Maidan, I; Manor, B; Mirelman, A	1
Andrusca, A; Deuschl, G; Gavriliuc, O; Helmers, AK; Paschen, S; Schlenstedt, C	1
Abdelrahman, A; Ahmed, OG; Mahmoud, ME; Monir, DM; Rehan, IF	1
Guo, W; Liu, Y; Tang, X; Wang, X; Xu, Y; Yang, J; Yu, L	1
Akram, H; Aviles-Olmos, I; Cowie, D; Day, B; Dayal, V; Foltynie, T; Hariz, M; Hyam, J; Jahanshahi, M; Limousin, P; Peters, A; Rajabian, A; Zrinzo, L	1
Bonvegna, S; Cilia, R; Colucci, F; Cossu, G; De Micco, R; Eleopra, R; Elia, AE; Fabbri, M; Ielo, GC; Lopiano, L; Modugno, N; Morgante, F; Novelli, A; Olivola, E; Oppo, V; Pilleri, M; Ricciardi, L; Sensi, M; Sorbera, C; Tessitore, A; Zibetti, M	1
Bishop, C; Chambers, NE; Clark, SD; Coyle, M; Lanza, K; Saito, C; Sergio, J; Topping, B	1
Emamikhah, M; Ghadimi, M; Habibi, SAH; Moghaddasi, M; Rohani, M; Saeedi, Y; Shahidi, G	1
Bergmans, B; Cofré Lizama, LE; Dijkstra, BW; Gilat, M; Mancini, M; Nieuwboer, A; Verschueren, SMP	1
Baik, K; Chung, SJ; Hong, JM; Jung, JH; Kim, YJ; Lee, HS; Lee, PH; Lee, YH; Sohn, YH; Yoo, HS	1
Bossert, I; Brumberg, J; Ceravolo, R; Fasano, A; Isaias, IU; Minafra, B; Pacchetti, C; Pisano, P; Pozzi, NG; Todisco, M; Trifirò, G; Zangaglia, R	1
Fujioka, S; Komorita, S; Mishima, T; Nishida, A; Okajima, M; Tsuboi, Y	1
Baik, K; Chung, SJ; Jeong, SH; Jung, JH; Lee, PH; Lee, YH; Sohn, YH; Yoo, HS	1
Costa, CDM; de Freitas, JL; de Oliveira, MO; Ferraz, JB; Godinho, F; Hamani, C; Queiroz, JWM; Rocha, MSG; Soriano, DC; Tatsch, JFS; Terzian, PR	1
Ba, F; Chen, L; Gui, Y; Hu, X; Lai, HY; Lv, W; Shen, T; Xie, F; Yue, Y; Zhang, B; Zhang, W	1
Kang, SH; Kim, HJ; Koh, SB; Kwon, KY; Lee, HM; Pyo, SJ	1
Cicero, CE; Contrafatto, D; Dibilio, V; Luca, A; Mostile, G; Nicoletti, A; Raciti, L; Sciacca, G; Toscano, S; Vasta, R; Zappia, M	1
Angrisano, S; Artusi, CA; Dematteis, F; Lopiano, L; Merola, A; Romagnolo, A; Zibetti, M	1
Cantù, H; Côté, JN; Hill, A; Jehu, DA; Nantel, J; Paquette, C	1
Buhmann, C; Hauptmann, B; Modreanu, R; Özdemir, G	1
Baufreton, J; Bessière, B; Bezard, E; Chazalon, M; Courtine, G; Farjot, G; Ko, WKD; Li, Q; McGuire, S; Milekovic, T; Milet, A; Moraud, EM; Morin, S; Normand, E; Pioli, E; Porras, G; Pype, J; Sun, S	1
Cámara, A; Compta, Y; Martí, MJ; Muñoz, E; Roldán, P; Rumià, J; Tolosa, E; Valldeoriola, F	1
Denibaud, AS; Drieu La Rochelle, C; Loiodice, S; Méot, B; Montagne, P; Rion, B; Viel, R; Wing Young, H	1
Gharabaghi, A; Milosevic, L; Weiss, D	1
Valldeoriola, F	1
Konishi, O; Manabe, Y; Odawara, T	1
Azevedo, LF; Castro-Lopes, J; Cavaco, S; Damásio, J; Fernandes, J; Gonçalves, A; Mendes, A; Moreira, I; Vila-Chã, N	1
Bicho, E; Carvalho, C; Ferreira, C; Ferreira, F; Gago, MF; Gama, J; Mollaei, N; Rodrigues, L; Rodrigues, PP; Sousa, N	1
Chung, SJ; Kim, JS; Lee, PH; Lee, YH; Oh, JS; Sohn, YH; Ye, BS; Yoo, HS	1
Januário, C; Moreira, F; Rebelo Gomes, I	1
Ardouin, C; Benabid, AL; Chabardès, S; Debû, B; Ferraye, MU; Fraix, V; Krack, P; Lhommée, E; Pollak, P; Seigneuret, E	1
Giladi, N; Hausdorff, JM; Hendler, T; Herman, T; Jacob, Y; Rosenberg-Katz, K	1
Bolitho, SJ; Gilat, M; Kamsma, YP; Lewis, SJ; Matar, E; Naismith, SL; Shine, JM	1
Almeida, QJ; Caetano, MJ; Gobbi, LT; Gobbi, S; Pieruccini-Faria, F; Silveira, CR; Stella, F; Vitório, R	1
Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E	1
Fox, SH	1
Amarell, M; Barbe, MT; Bloem, BR; Fink, GR; Florin, E; Quatuor, EL; Schönau, E; Snijders, AH; Timmermann, L	1
Anheim, M; Biskup, S; Lagha-Boukbiza, O; Mallaret, M; Namer, IJ; Rudolf, G; Tranchant, C	1
Devos, H; Münks, L; Nieuwboer, A; Nuttin, B; Vandenberghe, W; Vercruysse, S	1
Bleuse, S; Defebvre, L; Delval, A; Devos, D; Moreau, C; Ryckewaert, G; Tard, C	1
Baker, R; Brant, R; Corrêa, JC; de Godoy, W; Greve, JM; Lucareli, PR; Luna, NM; Speciali, DS	1
Ceballos-Baumann, AO; Fietzek, UM; Schroeteler, FE; Ziegler, K; Zwosta, J	1
Andrade, DM; Borlot, F; Fasano, A; Lang, AE	1
Bloem, BR; Debû, B; Derost, P; Durif, F; Fraix, V; Krack, P; Lavenne, F; Le Bars, D; Maillet, A; Pollak, P; Redouté, J; Thobois, S	1
Burn, DJ; Galna, B; Lord, S; Rochester, L	1
Chang, FC; Drury, M; Fung, VS; Griffith, JM; Ha, AD; Kim, SD; Mahant, N; Tsui, DS; Wolfe, N	1
Alves, G; Forsaa, EB; Larsen, JP; Wentzel-Larsen, T	1
Cavanaugh, JT; Dibble, LE; Earhart, GM; Ellis, TD; Ford, MP; Foreman, KB	1
Abbruzzese, G; Amboni, M; Antonini, A; Attar, M; Barone, P; Colombo, D; Morgante, L; Onofrj, M; Ori, A; Ruggieri, S; Simoni, L; Stocchi, F; Tinazzi, M; Zappia, M	1
Bardinet, E; Belaid, H; Czernecki, V; Demain, A; El Helou, A; Ewenczyk, C; François, C; Grabli, D; Karachi, C; Lau, B; Welter, ML; Yelnik, J	1
Chiou, SM; Huang, HM; Lin, YC	1
Chen, HM; Fang, JP; Feng, T; Gao, LY; Hou, YN; Ma, LY; Wang, ZJ; Wu, T; Zhang, JR	1
Bryant, MS; Collins, RL; Hou, JG; Protas, EJ; Rintala, DH	1
Chen, H; Guo, Y; Hao, H; Jia, F; Li, L; Wan, S; Zhang, J	1
Canning, SD; Wang, XP; Zhang, LL	1
Bharath, RD; Jha, M; Jhunjhunwala, K; Lenka, A; Naduthota, RM; Pal, PK; Panda, R; Prajapati, A; Saini, J; Yadav, R	1
Arena, JE; Cerquetti, D; Chaves, H; Dossi, DE; Merello, M; Rollan, C; Rossi, M	1
Bardinet, E; Burkhard, P; Chabardes, S; Combescure, C; Fleury, V; Gere, J; Krack, P; Krainik, A; Momjian, S; Pollak, P; Romito, L; Tommasi, G; Yelnik, J	1
Carlson-Kuhta, P; Horak, FB; Mancini, M; Nutt, JG; Salarian, A	1
Carlson-Kuhta, P; Curtze, C; Horak, FB; Mancini, M; Nutt, JG	1
Horak, FB; Peterson, DS	2
Defebvre, L; Delval, A; Devanne, H; Tard, C	1
Ahlskog, JE; Bower, J; Hassan, A; Josephs, KA; Klassen, B; Maraganore, D; Matsumoto, J; Owens, E; Savica, R	1
Grabli, D	1
Bingefors, K; Isacson, D; Kristiansen, IS; Nyholm, D	1
Okuma, Y; Yanagisawa, N	1
Sethi, K	1
Bayliss, M; Harper, A; Nisbet, A; Saha, R; Scutt, A	1
Carpinella, I; Crenna, P; Ferrarin, M; Lanotte, M; Lopiano, L; Marzegan, A; Rabuffetti, M; Rizzone, M	1
De Nunzio, AM; Godi, M; Guglielmetti, S; Nardone, A; Schieppati, M	1
Azulay, T; Brooks, DJ; Giladi, N; Melamed, E; Oertel, W; Poewe, WH; Rascol, O; Stocchi, F; Tal, J; Tolosa, E	1
Benabid, AL; Chabardès, S; Debû, B; Ferraye, MU; Fraix, V; Gerardin, P; LeBas, JF; Pollak, P; Seigneuret, E; Tilikete, C	1
Devos, D	1
Jankovic, J	1
Abramov, VG; Nesterova, IuV; Pokhabov, DV	1
Gruendlinger, L; Hausdorff, JM; O'Herron, S; Scollins, L; Tarsy, D	1
Azulay, JP; Cantiniaux, S; Horrelou-Pitek, C; Mancini, J; Robert, D; Vaugoyeau, M; Witjas, T	1
Bordet, R; Defebvre, L; Devos, D	1
Enzinger, C; Katschnig, P; Linhart, WE; Ott, E; Schwingenschuh, P; Steinwender, G; Svehlík, M; Zwick, EB	1
Cho, C; Cohen, B; Kudo, K; Kunin, M; Olanow, CW; Osaki, Y; Raphan, T	1
Bureau, G; Chagniel, L; Cyr, M; Lebel, M	1
Guertin, PA; Rouleau, P; Ung, RV	1
Baker, K; Burn, D; Lord, S; Nieuwboer, A; Rochester, L	1
Kim, BJ; Kim, JS; Kim, KK; Kim, SM; Lee, MC; Lim, YM; Park, HK	1
Cha, DR; Kang, YS; Koh, SB; Kwon, DY; Park, KW; Park, MH; Seo, WK	1
Adams, C; Keep, M; Kumar, R; Martin, K; McVicker, J	1
Corcos, DM; Foto, J; Hondzinski, JM; Kadivar, Z	1
Braschinsky, M; Doherty, K; Hotter, A; Lees, AJ; Ling, H; Lüüs, SM; Poewe, W; Taba, P	1
Baker, K; Burn, D; Nieuwboer, A; Rochester, L	1
Garcia-Ruiz, PJ	1
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R	1
Eng, M; Eura, N; Furiya, Y; Ikada, Y; Ikeda, M; Izumi, T; Kataoka, H; Kiriyama, T; Kitauti, T; Saeki, K; Sugie, K; Tanaka, N; Ueno, S	1
Gupta, D; Kuruvilla, A	1
Bryant, MS; Hou, JG; Lai, EC; Protas, EJ; Rintala, DH	1
Bloem, BR; Espay, AJ; Fasano, A; Payne, MM; Snijders, AH; van Nuenen, BF	1
Chen, R	1
Imamura, K; Nagatsu, T; Okayasu, N	1
Bernardo, M; Fernández-Egea, E; Martí, MJ; Muñiz, A; Pintor, LP; Rami, L; Sánchez, R; Tolosa, E; Valldeoriola, F	1
Tarsy, D	1
Afzal, M; Jyoti, S; Khan, S; Naz, F; Shakya, B; Siddique, YH	1
Agosti, V; Amboni, M; Barone, P; Fasano, A; Iavarone, A; Iuppariello, L; Lista, I; Picillo, M; Santangelo, G; Sorrentino, G; Tranfaglia, R; Vitale, C	1
Barbe, MT; Eggers, C; Pauls, KA; Salimi Dafsari, H; Timmermann, L	1
Foley, P	1
Allorge, D; Blum, D; Bordet, R; Defebvre, L; Delval, A; Destée, A; Devos, D; Duhamel, A; Dujardin, K; Hossein-Foucher, C; Moreau, C; Petyt, G; Sablonnière, B; Schraen, S; Tiffreau, V	1
Barker, RA; Brooks, DJ; Burn, DJ; Coleman, S; Duncan, GW; Khoo, TK; O'Brien, JT; Yarnall, AJ	1
Factor, SA; Jennings, DL; Marek, KL; Molho, ES	1
Blatt, JL; Blond, S; Bourriez, JL; Defebvre, L; Destée, A; Duhamel, A; Guieu, JD; Krystkowiak, P; Perina, M	1
Minagar, A; Shulman, LM; Weiner, WJ	1
Balash, Y; Bartels, AL; Giladi, N; Gurevich, T; Hausdorff, JM; Schaafsma, JD	4
Shinohara, Y; Takahashi, H	1
Hirato, M; Kita, K; Kondo, T; Okamoto, K; Yuasa, T	1
Pagni, CA; Zeme, S; Zenga, F	1
Huxham, F; Iansek, R; Matyas, T; McGinley, J; Morris, M	1
Kang, SY; Lee, MH; Lee, SK; Sohn, YH	1
Bergamasco, B; Ferrarin, M; Lanotte, M; Lopiano, L; Pedotti, A; Recalcati, M; Rizzone, M	1
Chu, NS	1
Magnani, P; Mailland, E; Ottillinger, B	1
Kim, HS; Lee, MS; Lyoo, CH	1
Carlson, NE; Chung, KA; Nutt, JG	1
Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK	1
Van Gerpen, JA	1
Carlson-Kuhta, P; Chiari, L; Gross, A; Horak, FB; Mancini, M; Rocchi, L	1
Grant, PE; Sims, KB; Venna, N	1
Cohen, HS; Gracies, JM; MacDougall, HG; Moore, ST; Ondo, WG	1
Weiner, WJ	1
Brusa, L; Galati, S; Lozano, AM; Mazzone, P; Peppe, A; Pierantozzi, M; Scarnati, E; Stanzione, P; Stefani, A; Tropepi, D	1
Aalto, S; Chang, JW; Lee, KO; Lee, MS; Lyoo, CH; Oh, SH; Rinne, JO	1
Ho, B; Morgan, JC; Prakash, R; Sethi, KD	1
MacDougall, HG; Moore, ST; Ondo, WG	1
Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K	1
Baker, R; Huxham, F; Iansek, R; Morris, ME	1
Chung, SJ; Ki, CS; Kim, MJ; Lee, MC; Park, HK	1
Brown, P; Doyle, LM; Lees, AJ; Williams, DR	1
Cheyette, BN; Cheyette, SN; Cusmano-Ozog, K; Enns, GM	1
Anderson, KE; Fishman, PS; Gruber-Baldini, AL; Reich, SG; Shulman, LM; Vaughan, CG; Weiner, WJ	1
Giladi, N; Hausdorff, JM; Plotnik, M	1
Benabid, AL; Chabardès, S; Debû, B; Ferraye, MU; Fraix, V; Krack, P; Pollak, P; Xie-Brustolin, J	1
Amblard, B; Azulay, JP; Mesure, S; Pouget, J	1
Giladi, N; Kandinov, B; Korczyn, AD; Orlov, Y; Paleacu, D; Shabtai, H; Simon, ES; Treves, TA	1
Berger, W; Faist, M; Kurz, D; Lücking, CH; Maurer, C; Pollak, P; Xie, J	1
Albanese, A; Bentivoglio, AR; Cortelli, P; Elia, A; Ferraris, A; Ialongo, T; Montagna, P; Valente, EM	1
Bindoff, LA; Farbu, E	1
Benabid, AL; Krack, P; Pollak, P; Xie, J	1

Reviews

13 review(s) available for levodopa and Ambulation Disorders, Neurologic

Article	Year
Freezing of gait: overview on etiology, treatment, and future directions. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:3 Topics: Causality; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2022
Cognition and freezing of gait in Parkinson's disease: A systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 2023, Volume: 147 Topics: Cognition; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2023
Non-dopaminergic treatments for motor control in Parkinson's disease. Drugs, 2013, Volume: 73, Issue:13 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Dopamine Agents; Drug Resistance; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Humans; Levodopa; Mesencephalon; Molecular Targeted Therapy; Monoamine Oxidase Inhibitors; Neurons; Off-Label Use; Parkinson Disease; Serotonin Antagonists; Tremor	2013
Freezing of Gait in Parkinsonism and its Potential Drug Treatment. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Botulinum Toxins; Droxidopa; Gait Disorders, Neurologic; Humans; Indans; Levodopa; Methylphenidate; Middle Aged; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Selegiline; Treatment Outcome	2016
Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:9 Topics: Adult; Aged; Combined Modality Therapy; Deep Brain Stimulation; Dopamine Agents; Dyskinesias; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus	2016
Presse medicale (Paris, France : 1983), 2017, Volume: 46, Issue:2 Pt 1 Topics: Antiparkinson Agents; Articulation Disorders; Corpus Striatum; Deglutition Disorders; Disease Progression; Dopamine Agonists; Dopaminergic Neurons; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Movement; Muscle Hypertonia; Parkinson Disease; Parkinsonian Disorders; Postural Balance; Sensation Disorders; Substantia Nigra; Tremor	2017
The clinical spectrum of freezing of gait in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 2 Topics: Disease Progression; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2008
Levodopa unresponsive symptoms in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3 Topics: Antiparkinson Agents; Anxiety; Depression; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Sweating; Xerostomia	2008
[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease]. Revue neurologique, 2010, Volume: 166, Issue:2 Topics: Accidental Falls; Antiparkinson Agents; Cholinergic Agents; Dopamine Agents; Droxidopa; Gait Disorders, Neurologic; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Serotonin Receptor Agonists; Synaptic Transmission	2010
Vascular parkinsonism: what makes it different? Postgraduate medical journal, 2011, Volume: 87, Issue:1034 Topics: Antiparkinson Agents; Brain Ischemia; Dementia; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease, Secondary	2011
[Parkinson's disease: current standards in diagnostics and therapy]. Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:10 Topics: Antidepressive Agents; Antiparkinson Agents; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Drug Implants; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Tremor	2012
[Diagnosis and therapy for patients with vascular parkinsonism]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosis, Differential; Gait Disorders, Neurologic; Humans; Levodopa; Muscle Rigidity; Parkinson Disease, Secondary; Platelet Aggregation Inhibitors; Posture; Secondary Prevention; Tremor	2003
Motor fluctuations in Parkinson's disease. Reviews in neurological diseases, 2006,Summer, Volume: 3, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Motor Activity; Neurosurgical Procedures; Parkinson Disease; Tremor	2006

Trials

21 trial(s) available for levodopa and Ambulation Disorders, Neurologic

Article	Year
The Minimal Clinically Relevant Change of the FOG Score. Journal of Parkinson's disease, 2020, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Minimal Clinically Important Difference; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Video Recording	2020
Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study. Parkinsonism & related disorders, 2019, Volume: 60 Topics: Aged; Cross-Over Studies; Deep Brain Stimulation; Dopamine Agents; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease; Pilot Projects; Single-Blind Method; Substantia Nigra; Subthalamic Nucleus	2019
Auditory cueing of gait initiation in Parkinson's disease patients with freezing of gait. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2014, Volume: 125, Issue:8 Topics: Analysis of Variance; Cues; Dopamine Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture	2014
Randomized cross-over trial to investigate the efficacy of a two-week physiotherapy programme with repetitive exercises of cueing to reduce the severity of freezing of gait in patients with Parkinson's disease. Clinical rehabilitation, 2014, Volume: 28, Issue:9 Topics: Aged; Cross-Over Studies; Cues; Exercise Therapy; Female; Gait Disorders, Neurologic; Germany; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Outpatients; Parkinson Disease; Severity of Illness Index	2014
PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. Journal of neurology, 2015, Volume: 262, Issue:6 Topics: Aged; Antiparasitic Agents; Deep Brain Stimulation; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Postural Balance; Sensation Disorders; Surveys and Questionnaires	2015
Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease. Neuroscience letters, 2016, 08-15, Volume: 628 Topics: Aged; Biomechanical Phenomena; Cross-Over Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prefrontal Cortex; Transcranial Magnetic Stimulation; Treatment Outcome	2016
Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta neurologica Scandinavica, 2008, Volume: 118, Issue:6 Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Depressive Disorder; Disease Progression; Duodenum; Female; Gait Disorders, Neurologic; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Patient Satisfaction; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome	2008
Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Apr-15, Volume: 24, Issue:5 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Catechols; Double-Blind Method; Female; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Indans; Levodopa; Male; Middle Aged; Neuroprotective Agents; Nitriles; Parkinson Disease; Principal Component Analysis; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Statistics as Topic; Surveys and Questionnaires	2009
Atomoxetine for freezing of gait in Parkinson disease. Journal of the neurological sciences, 2009, Sep-15, Volume: 284, Issue:1-2 Topics: Adrenergic Uptake Inhibitors; Aged; Antiparkinson Agents; Atomoxetine Hydrochloride; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propylamines; Severity of Illness Index	2009
Deep brain stimulation effects on gait variability in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Aug-15, Volume: 24, Issue:11 Topics: Accidental Falls; Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Risk; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome	2009
Effect of step training and rhythmic auditory stimulation on functional performance in Parkinson patients. Neurorehabilitation and neural repair, 2011, Volume: 25, Issue:7 Topics: Acoustic Stimulation; Aged; Aged, 80 and over; Antiparkinson Agents; Exercise Therapy; Female; Functional Laterality; Gait; Gait Disorders, Neurologic; Humans; Learning; Levodopa; Male; Middle Aged; Parkinson Disease; Physical Therapy Modalities; Postural Balance; Treatment Outcome	2011
Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues. Movement disorders : official journal of the Movement Disorder Society, 2011, Feb-15, Volume: 26, Issue:3 Topics: Aged; Antiparkinson Agents; Cues; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Walking	2011
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study. Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Disability Evaluation; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Memantine; Middle Aged; Parkinson Disease; Pilot Projects; Sample Size	2013
Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease. Archives of neurology, 2003, Volume: 60, Issue:1 Topics: Antiparkinson Agents; Combined Modality Therapy; Electric Stimulation Therapy; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome	2003
Further experience with extradural motor cortex stimulation for treatment of advanced Parkinson's disease. Report of 3 new cases. Journal of neurosurgical sciences, 2003, Volume: 47, Issue:4 Topics: Aged; Deglutition Disorders; Dura Mater; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Motor Cortex; Muscle Rigidity; Parkinson Disease; Treatment Outcome; Tremor	2003
Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:1 Topics: Aged; Ankle Joint; Antiparkinson Agents; Biomechanical Phenomena; Cues; Female; Gait Disorders, Neurologic; Hip; Humans; Knee; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance	2005
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease. Experimental brain research, 2005, Volume: 160, Issue:4 Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Deep Brain Stimulation; Electrodes, Implanted; Female; Functional Laterality; Gait; Gait Disorders, Neurologic; Humans; Leg; Levodopa; Male; Middle Aged; Parkinson Disease; Range of Motion, Articular; Recovery of Function; Subthalamic Nucleus; Treatment Outcome	2005
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease. Arzneimittel-Forschung, 2004, Volume: 54, Issue:10 Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor	2004
Short-term paroxetine treatment does not alter the motor response to levodopa in PD. Neurology, 2005, May-24, Volume: 64, Issue:10 Topics: Accidental Falls; Aged; Brain; Cross-Over Studies; Dizziness; Dopamine; Dopamine Agents; Double-Blind Method; Drug Interactions; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Paroxetine; Presynaptic Terminals; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Failure; Vestibular Diseases	2005
Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain : a journal of neurology, 2001, Volume: 124, Issue:Pt 8 Topics: Adult; Antiparkinson Agents; Electric Stimulation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome	2001
Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait. Journal of neurology, 2001, Volume: 248, Issue:12 Topics: Adult; Aged; Antiparkinson Agents; Dopamine Agonists; Electric Stimulation Therapy; Female; Gait; Gait Disorders, Neurologic; Humans; Leg; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus	2001

Other Studies

137 other study(ies) available for levodopa and Ambulation Disorders, Neurologic

Article	Year
Falls risk is predictive of dysphagia in Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:2 Topics: Accidental Falls; Deglutition Disorders; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2022
The effects of levodopa in the spatiotemporal gait parameters are mediated by self-selected gait speed in Parkinson's disease. The European journal of neuroscience, 2021, Volume: 54, Issue:11 Topics: Bayes Theorem; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Walking Speed	2021
Factors correlated with therapeutic effects of globus pallidus deep brain stimulation on freezing of gait in advanced Parkinson's disease: A pilot study. Parkinsonism & related disorders, 2022, Volume: 94 Topics: Deep Brain Stimulation; Gait; Gait Disorders, Neurologic; Globus Pallidus; Humans; Levodopa; Parkinson Disease; Pilot Projects; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome	2022
The correlation between genetic factors and freezing of gait in patients with Parkinson's disease. Parkinsonism & related disorders, 2022, Volume: 98 Topics: Antiparkinson Agents; Catechol O-Methyltransferase; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Protein Serine-Threonine Kinases; Receptors, Dopamine D2	2022
Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype. PloS one, 2022, Volume: 17, Issue:6 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Phenotype; Quality of Life	2022
Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease? Parkinsonism & related disorders, 2022, Volume: 102 Topics: Dopamine; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Prognosis	2022
Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS). Parkinsonism & related disorders, 2022, Volume: 105 Topics: Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Drug Combinations; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Parkinson Disease; Quality of Life; Retrospective Studies	2022
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease. European journal of neurology, 2023, Volume: 30, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesias; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Middle Aged; Parkinson Disease; Posture	2023
Levodopa alters resting-state functional connectivity more selectively in Parkinson's disease with freezing of gait. The European journal of neuroscience, 2023, Volume: 57, Issue:1 Topics: Brain; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease	2023
Reduced Short-Latency Afferent Inhibition in Parkinson's Disease Patients with L-dopa-Unresponsive Freezing of Gait. Journal of Parkinson's disease, 2022, Volume: 12, Issue:8 Topics: Dopamine; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Walking	2022
Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease. Neurobiology of disease, 2023, Volume: 179 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Norepinephrine Plasma Membrane Transport Proteins; Parkinson Disease	2023
Long-term levodopa ameliorates sequence effect in simple, but not complex walking in early Parkinson's disease patients. Parkinsonism & related disorders, 2023, Volume: 108 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Walking	2023
An Explainable Spatial-Temporal Graphical Convolutional Network to Score Freezing of Gait in Parkinsonian Patients. Sensors (Basel, Switzerland), 2023, Feb-04, Volume: 23, Issue:4 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Movement; Parkinson Disease	2023
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson's Disease Converting to a Freezing of Gait Phenotype. Journal of Parkinson's disease, 2023, Volume: 13, Issue:6 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2023
Cortical Disinhibition Drives Freezing of Gait in Parkinson's Disease and an Exploratory Repetitive Transcranial Magnetic Stimulation Study. Movement disorders : official journal of the Movement Disorder Society, 2023, Volume: 38, Issue:11 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Transcranial Magnetic Stimulation	2023
Forward and backward walking in Parkinson disease: A factor analysis. Gait & posture, 2019, Volume: 74 Topics: Aged; Case-Control Studies; Factor Analysis, Statistical; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Walking	2019
Freezing of Gait and Its Levodopa Paradox. JAMA neurology, 2020, 03-01, Volume: 77, Issue:3 Topics: Antiparkinson Agents; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2020
"On-State" Freezing of Gait: Insights and Treatment With Levodopa Intestinal Gel Infusion. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gait; Gait Disorders, Neurologic; Gels; Humans; Levodopa; Parkinson Disease	2020
Initial motor reserve and long-term prognosis in Parkinson's disease. Neurobiology of aging, 2020, Volume: 92 Topics: Aged; Corpus Striatum; Disease Progression; Dopamine; Dyskinesias; Female; Gait Disorders, Neurologic; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Parkinson Disease; Prognosis; Time Factors	2020
Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease. Journal of Parkinson's disease, 2020, Volume: 10, Issue:3 Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease	2020
Predictors of Pharyngeal Dysphagia in Patients with Parkinson's Disease. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Age Factors; Aged; Antiparkinson Agents; Deglutition Disorders; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Risk; Severity of Illness Index; Tremor	2020
Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson's disease: does the levodopa overdose hypothesis extend to gait? Journal of neurology, 2021, Volume: 268, Issue:2 Topics: Dopamine; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Walking	2021
Clinical patterns of gait freezing in Parkinson's disease and their response to interventions: An observer-blinded study. Parkinsonism & related disorders, 2020, Volume: 80 Topics: Adult; Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Single-Blind Method; Subthalamic Nucleus; Treatment Outcome; Video Recording	2020
Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson's disease in rotenone-treated rats. Behavioral and brain functions : BBF, 2020, Nov-06, Volume: 16, Issue:1 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Gait Disorders, Neurologic; Levodopa; Male; Memory, Short-Term; Movement Disorders; Neostriatum; NF-E2-Related Factor 2; Parkinson Disease, Secondary; Physical Conditioning, Animal; Psychomotor Performance; Rats; Rats, Wistar; Rotenone; Signal Transduction; Tyrosine 3-Monooxygenase; Uncoupling Agents; Up-Regulation	2020
Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021, 04-01, Volume: 17, Issue:4 Topics: Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Sleep	2021
Pedunculopontine Nucleus Deep Brain Stimulation for Parkinsonian Disorders: A Case Series. Stereotactic and functional neurosurgery, 2021, Volume: 99, Issue:4 Topics: Deep Brain Stimulation; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Pedunculopontine Tegmental Nucleus	2021
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age. Journal of neurology, 2021, Volume: 268, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Drug Combinations; Gait Disorders, Neurologic; Gels; Humans; Italy; Levodopa; Parkinson Disease; Quality of Life	2021
Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats. The European journal of neuroscience, 2021, Volume: 53, Issue:8 Topics: Animals; Cholinergic Agents; Disease Models, Animal; Dyskinesias; Gait; Gait Disorders, Neurologic; Levodopa; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley	2021
Impact of anticholinergic drugs withdrawal on motor function in patients with Parkinson's disease. Clinical neurology and neurosurgery, 2021, Volume: 202 Topics: Accidental Falls; Adult; Aged; Antiparkinson Agents; Cholinergic Antagonists; Female; Gait; Gait Disorders, Neurologic; Humans; Incidence; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Time Factors	2021
Impaired Weight-Shift Amplitude in People with Parkinson's Disease with Freezing of Gait. Journal of Parkinson's disease, 2021, Volume: 11, Issue:3 Topics: Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2021
Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson's Disease. The journals of gerontology. Series A, Biological sciences and medical sciences, 2021, 11-15, Volume: 76, Issue:12 Topics: Antiparkinson Agents; Body Weight; Dyskinesias; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle, Skeletal; Parkinson Disease; Sarcopenia	2021
Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus. Neurology, 2021, 06-08, Volume: 96, Issue:23 Topics: Aged; Aged, 80 and over; Cerebrospinal Fluid Shunts; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Hydrocephalus, Normal Pressure; Levodopa; Male; Neostriatum; Outcome Assessment, Health Care; Parkinsonian Disorders; Phenotype; Postural Balance; Tomography, Emission-Computed, Single-Photon	2021
[Optimal dose of levodopa-carbidopa intestinal gel in the treatment of diphasic dyskinesia and freezing of gait]. Rinsho shinkeigaku = Clinical neurology, 2021, Jun-29, Volume: 61, Issue:6 Topics: Activities of Daily Living; Carbidopa; Dyskinesias; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Middle Aged; Parkinson Disease	2021
Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson's Disease. Journal of Parkinson's disease, 2021, Volume: 11, Issue:4 Topics: Disease Progression; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2021
Fields of Forel Brain Stimulation Improves Levodopa-Unresponsive Gait and Balance Disorders in Parkinson's Disease. Neurosurgery, 2021, 08-16, Volume: 89, Issue:3 Topics: Brain; Deep Brain Stimulation; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Postural Balance; Quality of Life	2021
Normal-sized basal ganglia perivascular space related to motor phenotype in Parkinson freezers. Aging, 2021, 07-27, Volume: 13, Issue:14 Topics: Aged; Basal Ganglia; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Phenotype	2021
Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length. Gait & posture, 2017, Volume: 58 Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Walking; Walking Speed	2017
Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:12 Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Postural Balance; Severity of Illness Index	2017
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease. Journal of the neurological sciences, 2018, 02-15, Volume: 385 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2018
Medication and trial duration influence postural and pointing parameters during a standing repetitive pointing task in individuals with Parkinson's disease. PloS one, 2018, Volume: 13, Issue:4 Topics: Accidental Falls; Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Postural Balance; Posture; Surveys and Questionnaires	2018
Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing. Journal of the neurological sciences, 2018, 05-15, Volume: 388 Topics: Aged; Diagnosis, Differential; Dopamine Agents; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Supranuclear Palsy, Progressive	2018
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Administration, Inhalation; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Green Fluorescent Proteins; Levodopa; Mice; Mice, Transgenic; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Rats; Sensation Disorders; Sympatholytics; Time Factors; Xenon	2018
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease. Behavioural brain research, 2019, 03-15, Volume: 360 Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; Forelimb; Gait Disorders, Neurologic; Interpersonal Relations; Levodopa; Locomotion; Male; Maze Learning; Memory Disorders; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase	2019
Deep brain stimulation of the substantia nigra for freezing of gait in Parkinson's disease: is it about stimulation frequency? Parkinsonism & related disorders, 2019, Volume: 63 Topics: Deep Brain Stimulation; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Pars Reticulata; Pilot Projects; Substantia Nigra; Subthalamic Nucleus	2019
Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study. Parkinsonism & related disorders, 2019, Volume: 63 Topics: Deep Brain Stimulation; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease; Pars Reticulata; Pilot Projects; Substantia Nigra; Subthalamic Nucleus	2019
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2019, Volume: 19, Issue:4 Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor	2019
Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease. European journal of pain (London, England), 2019, Volume: 23, Issue:8 Topics: Aged; Antiparkinson Agents; Anxiety; Depression; Disabled Persons; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neuralgia; Parkinson Disease; Surveys and Questionnaires	2019
Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism. Journal of biomechanics, 2019, Jul-19, Volume: 92 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Foot; Gait Disorders, Neurologic; Humans; Kinetics; Levodopa; Longitudinal Studies; Male; Parkinsonian Disorders; Walking	2019
White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2019, Volume: 66 Topics: Aged; Antiparkinson Agents; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prognosis; Retrospective Studies; White Matter	2019
Freezing of gait and postural instability: the unpredictable response to levodopa in Parkinson's disease. BMJ case reports, 2019, Jul-22, Volume: 12, Issue:7 Topics: Aged; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Humans; Levodopa; Male; Oxadiazoles; Parkinson Disease; Postural Balance; Sensation Disorders	2019
Levodopa-resistant freezing of gait and executive dysfunction in Parkinson's disease. European neurology, 2013, Volume: 69, Issue:5 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Executive Function; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Retrospective Studies; Severity of Illness Index; Subthalamic Nucleus	2013
Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology, 2013, Apr-16, Volume: 80, Issue:16 Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Cognition; Data Interpretation, Statistical; Female; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Nerve Net; Neural Pathways; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Risk Factors	2013
Variability of Stepping during a Virtual Reality Paradigm in Parkinson's Disease Patients with and without Freezing of Gait. PloS one, 2013, Volume: 8, Issue:6 Topics: Aged; Antiparkinson Agents; Computer Simulation; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Middle Aged; Parkinson Disease	2013
Evaluating the acute contributions of dopaminergic replacement to gait with obstacles in Parkinson's disease. Journal of motor behavior, 2013, Volume: 45, Issue:5 Topics: Aged; Anticipation, Psychological; Antiparkinson Agents; Biomechanical Phenomena; Cues; Data Interpretation, Statistical; Dopamine Agents; Female; Foot; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Photic Stimulation; Proprioception; Reproducibility of Results	2013
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10 Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor	2013
Gait and upper limb variability in Parkinson's disease patients with and without freezing of gait. Journal of neurology, 2014, Volume: 261, Issue:2 Topics: Aged; Antiparkinson Agents; Data Interpretation, Statistical; Dyskinesias; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Surveys and Questionnaires; Upper Extremity	2014
SPG15: a cause of juvenile atypical levodopa responsive parkinsonism. Journal of neurology, 2014, Volume: 261, Issue:2 Topics: Adolescent; Antiparkinson Agents; Brain; Carrier Proteins; Consanguinity; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Paraplegia; Parkinson Disease	2014
Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Adult; Aged; Antiparkinson Agents; Cohort Studies; Deep Brain Stimulation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Subthalamic Nucleus; Treatment Outcome	2014
Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa. Gait & posture, 2014, Volume: 39, Issue:4 Topics: Analysis of Variance; Antiparkinson Agents; Deep Brain Stimulation; Female; Gait Disorders, Neurologic; Humans; Joints; Levodopa; Lower Extremity; Male; Middle Aged; Parkinson Disease; Pelvis; Walking	2014
Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome. Neurology, 2014, Jun-17, Volume: 82, Issue:24 Topics: Antiparkinson Agents; Epilepsies, Myoclonic; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinsonian Disorders; Sensation Disorders; Statistics, Nonparametric; Videotape Recording	2014
Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach. Human brain mapping, 2015, Volume: 36, Issue:3 Topics: Aged; Antiparkinson Agents; Brain; Female; Gait Disorders, Neurologic; Humans; Imagination; Kinesthesis; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography	2015
Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:3 Topics: Aged; Cognition Disorders; Cohort Studies; Disability Evaluation; Disease Progression; Dopamine Agents; Female; Gait Disorders, Neurologic; Humans; Incidence; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenotype; Walking	2015
24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:3 Topics: Accidental Falls; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Time Factors	2015
A 12-year population-based study of freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Community Health Planning; Female; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors; Severity of Illness Index	2015
Toward Understanding Ambulatory Activity Decline in Parkinson Disease. Physical therapy, 2015, Volume: 95, Issue:8 Topics: Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Levodopa; Longitudinal Studies; Male; Mobility Limitation; Parkinson Disease; Postural Balance; Prospective Studies; Quality of Life; Self Efficacy; Surveys and Questionnaires; Upper Extremity	2015
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study. Parkinsonism & related disorders, 2015, Volume: 21, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Freezing Reaction, Cataleptic; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Quality of Life; Risk Factors; Self Report; Severity of Illness Index; Surveys and Questionnaires	2015
One-year Outcome of Bilateral Subthalamic Stimulation in Parkinson Disease: An Eastern Experience. World neurosurgery, 2015, Volume: 84, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Cohort Studies; Deep Brain Stimulation; Disease Progression; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Postoperative Complications; Retrospective Studies; Speech Disorders; Subthalamic Nucleus; Taiwan; Treatment Outcome	2015
Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson's disease: a resting-state fMRI study. CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:10 Topics: Adult; Aged; Antiparkinson Agents; Brain; Brain Mapping; Female; Gait Disorders, Neurologic; Gray Matter; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Organ Size; Parkinson Disease; Rest; Tremor	2015
Gait variability in Parkinson's disease: levodopa and walking direction. Acta neurologica Scandinavica, 2016, Volume: 134, Issue:1 Topics: Aged; Antiparkinson Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2016
Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:12 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Deep Brain Stimulation; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Pramipexole; Subthalamic Nucleus	2015
Freezing of gait in Parkinson's disease is associated with altered functional brain connectivity. Parkinsonism & related disorders, 2016, Volume: 24 Topics: Adult; Aged; Antiparasitic Agents; Brain; Disability Evaluation; Female; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Oxygen; Parkinson Disease; Severity of Illness Index	2016
Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 24 Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; White Matter	2016
Balance and Gait Represent Independent Domains of Mobility in Parkinson Disease. Physical therapy, 2016, Volume: 96, Issue:9 Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Cross-Sectional Studies; Factor Analysis, Statistical; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mobility Limitation; Parkinson Disease; Postural Balance; Signal Processing, Computer-Assisted	2016
Objective Gait and Balance Impairments Relate to Balance Confidence and Perceived Mobility in People With Parkinson Disease. Physical therapy, 2016, Volume: 96, Issue:11 Topics: Aged; Aged, 80 and over; Disability Evaluation; Dopamine Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Monitoring, Ambulatory; Parkinson Disease; Postural Balance; Severity of Illness Index; Surveys and Questionnaires	2016
The Effect of Levodopa on Improvements in Protective Stepping in People With Parkinson's Disease. Neurorehabilitation and neural repair, 2016, Volume: 30, Issue:10 Topics: Aged; Antiparkinson Agents; Female; Follow-Up Studies; Gait Disorders, Neurologic; Generalization, Psychological; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Retention, Psychology	2016
Effects of freezing of gait on postural motor learning in people with Parkinson's disease. Neuroscience, 2016, Oct-15, Volume: 334 Topics: Accidental Falls; Aged; Antiparkinson Agents; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Learning; Levodopa; Male; Memory; Motor Activity; Parkinson Disease; Posture	2016
The clinical spectrum and natural history of pure akinesia with gait freezing. Journal of neurology, 2016, Volume: 263, Issue:12 Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Follow-Up Studies; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Neuroimaging; Postural Balance; Psychomotor Performance; Retrospective Studies	2016
Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan. Age and ageing, 2008, Volume: 37, Issue:6 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Diagnosis, Differential; Dopamine Agents; Drug Therapy, Combination; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Pramipexole; Tremor	2008
Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease. Brain : a journal of neurology, 2008, Volume: 131, Issue:Pt 12 Topics: Aged; Arm; Basal Ganglia; Combined Modality Therapy; Deep Brain Stimulation; Exercise Test; Gait Disorders, Neurologic; Humans; Levodopa; Middle Aged; Parkinson Disease; Psychomotor Performance; Thigh	2008
Walking along circular trajectories in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Mar-15, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Exercise Therapy; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Psychomotor Performance; Regression Analysis; Severity of Illness Index; Walking	2009
Pedunculopontine nucleus stimulation induces monocular oscillopsia. Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:2 Topics: Aged; Antiparkinson Agents; Electric Stimulation; Electrodes, Implanted; Eye Movements; Gait Disorders, Neurologic; Humans; Levodopa; Mesencephalon; Oculomotor Nerve Diseases; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Vision, Monocular	2009
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Aged; Antiparkinson Agents; Dementia; Duodenum; Female; Gait Disorders, Neurologic; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Personal Autonomy; Quality of Life; Retrospective Studies; Treatment Outcome	2009
[Rehabilitation of gait disorders in patients with Parkinson's disease and vascular parkinsonism]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:2 Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Exercise Therapy; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	2009
Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? Journal of neurology, neurosurgery, and psychiatry, 2010, Volume: 81, Issue:2 Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Disorders; Walking	2010
Gait analysis in patients with Parkinson's disease off dopaminergic therapy. Archives of physical medicine and rehabilitation, 2009, Volume: 90, Issue:11 Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Disability Evaluation; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Range of Motion, Articular	2009
Frequency-velocity mismatch: a fundamental abnormality in parkinsonian gait. Journal of neurophysiology, 2010, Volume: 103, Issue:3 Topics: Acoustic Stimulation; Aged; Algorithms; Antiparkinson Agents; Biomechanical Phenomena; Feedback, Physiological; Female; Foot; Gait; Gait Disorders, Neurologic; Humans; In Vitro Techniques; Levodopa; Male; Middle Aged; Models, Neurological; Movement; Parkinsonian Disorders; Walking	2010
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. Neurobiology of disease, 2010, Volume: 38, Issue:1 Topics: Animals; Behavior, Animal; Biomarkers; Corpus Striatum; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gait Disorders, Neurologic; Infusion Pumps, Implantable; Levodopa; Locomotion; Male; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Signal Transduction; Thionucleotides	2010
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy. Biotechnology journal, 2010, Volume: 5, Issue:4 Topics: Administration, Oral; Animals; Biological Clocks; Buspirone; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Feasibility Studies; Gait Disorders, Neurologic; Levodopa; Male; Mice; Paraplegia; Serotonin Receptor Agonists; Spinal Cord	2010
Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction? Journal of neurology, 2011, Volume: 258, Issue:4 Topics: Aged; Attention; Depression; Dopamine Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Time Factors	2011
Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism. Journal of the neurological sciences, 2011, Feb-15, Volume: 301, Issue:1-2 Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Corpus Striatum; Fluorine Radioisotopes; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Radiopharmaceuticals; Substantia Nigra; Tremor; Tropanes	2011
Rapidly deteriorating parkinsonism and dysautonomia in patient with central pontine and extrapontine myelinolysis. Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:6 Topics: Antiparkinson Agents; Blood Pressure; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease; Primary Dysautonomias; Psychomotor Agitation	2011
Acute induction of levodopa-resistant freezing of gait upon subthalamic nucleus electrode implantation. Parkinsonism & related disorders, 2011, Volume: 17, Issue:6 Topics: Aged; Deep Brain Stimulation; Dopamine Agonists; Electrodes, Implanted; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Subthalamic Nucleus	2011
Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:7 Topics: Adult; Age of Onset; Antiparkinson Agents; Delayed Diagnosis; Diagnosis, Differential; Dystonic Disorders; Fatigue Syndrome, Chronic; Female; Gait Disorders, Neurologic; Humans; Levodopa; Parkinsonian Disorders; Time Factors; Ubiquitin-Protein Ligases; Young Adult	2011
Gait disturbances in Parkinson disease. Did freezing of gait exist before levodopa? Historical review. Journal of the neurological sciences, 2011, Aug-15, Volume: 307, Issue:1-2 Topics: Antiparkinson Agents; Disease Progression; Gait Disorders, Neurologic; History, 19th Century; Humans; Levodopa; Parkinson Disease	2011
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome	2012
Risk of falling in Parkinson's disease at the Hoehn-Yahr stage III. European neurology, 2011, Volume: 66, Issue:5 Topics: Accidental Falls; Aged; Antiparkinson Agents; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Logistic Models; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Surveys and Questionnaires; Video Recording	2011
Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease. NeuroRehabilitation, 2011, Volume: 29, Issue:3 Topics: Aged; Antiparkinson Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Walking	2011
"On" state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology, 2012, Feb-14, Volume: 78, Issue:7 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Behavior; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenotype	2012
Paradoxical worsening of gait with levodopa in Parkinson disease. Neurology, 2012, Feb-14, Volume: 78, Issue:7 Topics: Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease	2012
Cerebral blood flow and freezing of gait in Parkinson's disease. Acta neurologica Scandinavica, 2012, Volume: 126, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cerebrovascular Circulation; Disability Evaluation; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Humans; Iofetamine; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Selegiline; Tomography, Emission-Computed, Single-Photon	2012
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study. The journal of ECT, 2012, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Resistance; Electroconvulsive Therapy; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Pilot Projects; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Walking	2012
Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. JAMA, 2012, Jun-06, Volume: 307, Issue:21 Topics: Amantadine; Antiparasitic Agents; Carbidopa; Catechols; Decision Making; Deep Brain Stimulation; Disease Progression; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Subthalamus	2012
Effect of L-ascorbic Acid on the climbing ability and protein levels in the brain of Drosophila model of Parkinson's disease. The International journal of neuroscience, 2012, Volume: 122, Issue:12 Topics: Age Factors; alpha-Synuclein; Animals; Animals, Genetically Modified; Antioxidants; Antiparkinson Agents; Ascorbic Acid; Brain; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drosophila; Drosophila Proteins; Gait Disorders, Neurologic; Humans; Levodopa; Membrane Proteins; Neurons; Parkinson Disease; Transcription Factors	2012
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:12 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition Disorders; Executive Function; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Psychomotor Performance; Severity of Illness Index	2012
Mind the gap: Response to Garcia-Ruiz PJ (2011) Gait disturbances in Parkinson disease. Did freezing of gait exist before levodopa? Journal of the Neurological Sciences 307: 15-17. Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2 Topics: Antiparkinson Agents; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease	2012
The spectrum of nonmotor symptoms in early Parkinson disease. Neurology, 2013, Jan-15, Volume: 80, Issue:3 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Parkinson Disease; Surveys and Questionnaires	2013
The natural history of the syndrome of primary progressive freezing gait. Archives of neurology, 2002, Volume: 59, Issue:11 Topics: Aged; Aged, 80 and over; Cohort Studies; Diagnosis, Differential; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Radiography; Retrospective Studies; Syndrome	2002
Reversal of parkinsonism following liver transplantation. Neurology, 2003, Feb-11, Volume: 60, Issue:3 Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor	2003
Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait. Experimental brain research, 2003, Volume: 149, Issue:2 Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Regression Analysis; Statistics, Nonparametric; Walking	2003
Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. Journal of the neurological sciences, 2003, Aug-15, Volume: 212, Issue:1-2 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychiatric Status Rating Scales; Reference Values; Risk Factors; Time Factors	2003
Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Leg; Levodopa; Male; Middle Aged; Motion; Parkinsonian Disorders; Prevalence; Psychomotor Performance; Regression Analysis; Reproducibility of Results; Surveys and Questionnaires; Time Factors; Videotape Recording	2003
Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2003, Volume: 10, Issue:5 Topics: Antiparkinson Agents; Gait Ataxia; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Motor Activity; Movement Disorders; Parkinson Disease; Postural Balance; Speech Disorders; Tremor	2003
[Diagnosis and therapy for patients with Parkinson's disease (discussion)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Autonomic Nervous System Diseases; Disease Progression; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Life Style; Low Back Pain; Mental Disorders; Neurosurgical Procedures; Parkinson Disease; Stereotaxic Techniques	2003
Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. Parkinsonism & related disorders, 2004, Volume: 10, Issue:7 Topics: Adolescent; Antiparkinson Agents; Benztropine; Cognition Disorders; Corpus Callosum; Electroencephalography; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Weakness; Neuropsychological Tests; Parkinson Disease; Selegiline; Spastic Paraplegia, Hereditary; Tremor	2004
Effect of levodopa treatment for parkinsonism in welders: a double-blind study. Neurology, 2004, Oct-26, Volume: 63, Issue:8 Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding	2004
"Off" gait freezing and temporal discrimination threshold in patients with Parkinson disease. Neurology, 2005, Feb-22, Volume: 64, Issue:4 Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Perceptual Disorders; Posture; Reflex, Abnormal; Sensory Thresholds; Somatosensory Disorders; Time Perception; Toes; Touch	2005
Gender and the Parkinson's disease phenotype. Journal of neurology, 2005, Volume: 252, Issue:10 Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor	2005
Dopa-responsive dystonic camptocormia. Neurology, 2006, Jun-13, Volume: 66, Issue:11 Topics: Dopamine Agents; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Treatment Outcome	2006
Step initiation in Parkinson's disease: influence of initial stance conditions. Neuroscience letters, 2006, Oct-02, Volume: 406, Issue:1-2 Topics: Aged; Antiparkinson Agents; Basal Ganglia; Female; Gait; Gait Disorders, Neurologic; Humans; Leg; Levodopa; Male; Middle Aged; Neural Pathways; Parkinson Disease; Postural Balance	2006
Case records of the Massachusetts General Hospital. Case 26-2006. A 19-year-old woman with difficulty walking. The New England journal of medicine, 2006, Aug-24, Volume: 355, Issue:8 Topics: Adult; Diagnosis, Differential; Dystonia; Dystonic Disorders; Female; Gait Disorders, Neurologic; GTP Cyclohydrolase; Humans; Levodopa; Movement Disorders	2006
Long-term monitoring of gait in Parkinson's disease. Gait & posture, 2007, Volume: 26, Issue:2 Topics: Adult; Algorithms; Antiparkinson Agents; Calibration; Computers, Handheld; Drug Monitoring; Dyskinesia, Drug-Induced; Electronics, Medical; Feasibility Studies; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Monitoring, Ambulatory; Parkinson Disease	2007
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 6 Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Middle Aged; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Posture; Severity of Illness Index; Stereotaxic Techniques; Subthalamic Nucleus; Tomography, X-Ray Computed; Treatment Outcome	2007
Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait. Movement disorders : official journal of the Movement Disorder Society, 2007, Nov-15, Volume: 22, Issue:15 Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Cerebral Cortex; Combined Modality Therapy; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Subthalamic Nucleus	2007
A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease. Nature clinical practice. Neurology, 2007, Volume: 3, Issue:9 Topics: Diagnosis, Differential; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2007
Ambulatory monitoring of freezing of gait in Parkinson's disease. Journal of neuroscience methods, 2008, Jan-30, Volume: 167, Issue:2 Topics: Adult; Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Monitoring, Ambulatory; Parkinson Disease; Spectrum Analysis	2008
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Acta neurochirurgica, 2008, Volume: 150, Issue:1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor	2008
Footstep adjustments used to turn during walking in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6 Topics: Aged; Antiparkinson Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Reference Values; Walking	2008
Marked diurnal fluctuation and rest benefit in a patient with parkin mutation. Movement disorders : official journal of the Movement Disorder Society, 2008, Mar-15, Volume: 23, Issue:4 Topics: Adult; Circadian Rhythm; Diagnosis, Differential; Dopamine; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinsonian Disorders; Point Mutation; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tropanes; Ubiquitin-Protein Ligases; Videotape Recording	2008
The auditory startle response in parkinsonism may reveal the extent but not type of pathology. Journal of neurology, 2008, Volume: 255, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Auditory Pathways; Blinking; Brain Stem; Dementia; Diagnosis, Differential; Facial Muscles; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Ocular Motility Disorders; Parkinsonian Disorders; Predictive Value of Tests; Reflex, Startle; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tauopathies	2008
Dopa-responsive dystonia presenting as delayed and awkward gait. Pediatric neurology, 2008, Volume: 38, Issue:4 Topics: Carbidopa; Child, Preschool; Dopamine Agonists; Drug Combinations; Dystonic Disorders; Gait Disorders, Neurologic; GTP Cyclohydrolase; Humans; Levodopa; Male; Mutation; Pedigree	2008
The evolution of disability in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6 Topics: Activities of Daily Living; Aged; Diagnosis, Differential; Disabled Persons; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Self Care; Severity of Illness Index; Tremor	2008
Bilateral coordination of walking and freezing of gait in Parkinson's disease. The European journal of neuroscience, 2008, Volume: 27, Issue:8 Topics: Antiparkinson Agents; Female; Functional Laterality; Gait; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Walking	2008
Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease. Neurology, 2008, Apr-15, Volume: 70, Issue:16 Pt 2 Topics: Adult; Aged; Deep Brain Stimulation; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus	2008
Strategies of segmental stabilization during gait in Parkinson's disease. Experimental brain research, 1999, Volume: 129, Issue:4 Topics: Acceleration; Aged; Antiparkinson Agents; Child, Preschool; Female; Gait; Gait Disorders, Neurologic; Head Movements; Hip Joint; Humans; Infant; Leg; Levodopa; Male; Middle Aged; Parkinson Disease; Photic Stimulation; Psychomotor Performance; Shoulder Joint	1999
Freezing of gait in patients with advanced Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1 Topics: Adult; Age of Onset; Amantadine; Antiparkinson Agents; Disease Progression; Dopamine Agonists; Female; Freezing; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Regression Analysis; Retrospective Studies; Selegiline	2001
Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:6 Topics: Adult; Age of Onset; Aged; Chromosomes, Human, Pair 1; Diagnosis, Differential; Disease Progression; Dyskinesia, Drug-Induced; Female; Functional Laterality; Gait Disorders, Neurologic; Genes, Recessive; Haplotypes; Humans; Italy; Levodopa; Lod Score; Male; Middle Aged; Parkinsonian Disorders; Pedigree; Phenotype; Syndrome; Tremor; Videotape Recording	2001
[Dopa-responsive dystonia--a hereditary dystonia easy to treat]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Feb-10, Volume: 122, Issue:4 Topics: Adolescent; Adult; Antiparkinson Agents; Child; Diagnosis, Differential; Dopamine Agents; Dystonic Disorders; Female; Gait Disorders, Neurologic; GTP Cyclohydrolase; Humans; Levodopa; Male; Middle Aged; Pedigree	2002